Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
SP-420 by Pharmacosmos for Beta Thalassaemia: Likelihood of Approval
SP-420 is under clinical development by Pharmacosmos and currently in Phase II for Beta Thalassaemia. According to GlobalData, Phase II...